Introduction
Hepatocellular carcinoma (HCC), the predominant histological subtype of primary liver cancer (PLC), is one of the most frequent malignancies in the world. Because of the poor capacity of hepatocytes to grow in vitro, very few cytogenetic investigations have been reported. Chronic infections by hepatitis B (HBV) and C (HCV) viruses as well as heavy alcohol intake and dietary a¯atoxins represent the major risk factors of HCC. Although far more than 50% of HCCs are attributable to chronic HBV infection, the mechanisms by which HBV contributes to tumor formation remain unclear. In an eort to identify genetic abnormalities associated with HCC development, we and others had undertaken genome-wide explorations using loss of heterozygosity (LOH) assay and comparative genomic hybridization (Nagai et al., 1997; Boige et al., 1997; Marchio et al., 1997) . The most frequent losses were found on chromosome arms 1p, 4q, 6q, 8p, 13q, 16q and 17p. The over-represented regions were most prevalent on chromosome arms 1q, 6p, 8q and 17q. Among the genes mapping to these loci, the p53 gene located at 17p13.1, is the unique consistent tumor suppressor gene identi®ed so far (Puisieux et al., 1997) .
Fibrolamellar carcinoma (FLC) is a rare variant of HCC with distinct clinical and histological features. FLC typically occurs in young patients in the absence of any identi®able risk factors and/or underlying cirrhosis. The histological appearance is characterized by the existence of a mixture of abundant lamellar ®brous stroma and eosinophilic granular tumoral cells. The over-expression of the transforming growth factor b (TGFb) by the tumorous cells is most likely responsible for the development of the lamellar ®brosis that constitutes the histological hallmark of FLC (Orsatti et al., 1997) . Although several reports have emphasized the indolent growth of this subtype, the post-operative prognosis has been controversial, especially when comparison is performed with non-®brolamellar HCCs arising in non-cirrhotic livers (Craig et al., 1980) .
To evaluate the in¯uence of HBV infection on the genome of the tumorous hepatocytes, we studied a series of 34 non-B, non-C HCCs developed on noncirrhotic livers and compared the data to those obtained in a previous CGH analysis of 50 HBV positive HCCs associated or not with a cirrhosis (Marchio et al., 1997) . The two groups of tumors shared the same genetic abnormalities except for three, losses of chromosomes arms 4q, 16q and 17p, which were signi®cantly lower in the virus negative tumors. These data suggest the existence in these particular regions of candidate tumor suppressor genes which may be tightly linked to virus-associated liver carcinogenesis. In addition, to determine if genetic events commonly found in HCC are detectable in ®brolamel-lar carcinoma (FLC), 10 of them were analysed by CGH. Ampli®cation of chromosome arm 1q was frequently found in these tumors.
Results and discussion

Virus negative hepatocellular carcinoma
We have employed the CGH method to screen for imbalances in 34 HBV-negative, HCV-negative hepatocellular carcinoma specimens. Genomic abnormalities found in the 32 informative cases are summarized in Table 2 and schematically represented in Figure 1 . Overall, major changes detected in the present report are consistent with previous studies published hitherto (Marchio et al., 1997; Kusano et al., 1999; Sakakura et al., 1999; Wong et al., 1999) . The highest score of loss was found at chromosome 8p (62% of the tumors) followed by 13q, 4q, 14q, 6q, 17p, 1p and 16q (ranging from 28 ± 15%). Over-representations of 1q and 8q were detectable in 56 and 47% of the samples respectively, gains of 6p and 17q were also observed although to a lesser extent (37 and 22% respectively). In the remaining two Edmonson's grade I samples, no abnormality was detectable by CGH. This may be attributable to the low grade of the tumors usually associated with a small number of abnormalities (Kusano et al., 1999; Kuroki et al., 1995; Konishi et al., 1993) or alternatively to the limitation of the CGH technique which can not detect under-represented regions and amplicons smaller than 10 ± 20 and 2 megabases respectively (Bentz et al., 1998) .
No correlation was observed between the overall number of genetic alterations and the size of the tumors. By contrast, the average copy number changes in Edmonson-Steiner Grade I tumors (2.2+2.7/sample) were signi®cantly lower than in grade II (5+2.9, P50.02) and grade III (7.5+3.7, P50.01) as observed previously (Kusano et al., 1999; Kuroki et al., 1995; Konishi et al., 1993) . A signi®cant association was observed between loss of chromosome arms 8p (P50.02) or 13q (P50.01) and high tumor grade (grade I vs III). Loss of chromosome 8p appears as the major alteration in the present report, a situation reminiscent of that found in HBV positive tumors (Boige et al., 1997; Marchio et al., 1997) . In HCC, as in many other carcinomas, microsatellite studies have detected at least three distinct regions of loss on 8p, suggesting the presence of several tumor suppressor genes located on 8p21, 8p22 and 8p23 (Pineau et al., 1999; Lerebours et al., 1999; Wright et al., 1998) . The involvement of 8p losses in initiation or progression of HCC is currently not established. Indeed, in HCC as well as in oral and renal carcinoma, 8p loss has been associated with tumor progression, while it has been involved in the initiation process in breast carcinoma (Boige et al., 1997; Ishwad et al., 1999; Schullerus et al., 1999; Radford et al., 1995) . In the current report, a gain of 8q represents a frequent event (47%), almost systematically associated with loss of 8p (in 93% of the cases, P50.001). Cytogenetic investigations in HCC and various solid tumors have strongly suggested that the high prevalence of isochromosome 8q (i(8q)) is essentially due to a mechanical duplication of 8q arm as a consequence of 8p loss (Mertens et al., 1994) . However, in the present HCC series, 30% of 8p losses are not balanced by a symmetric gain of 8q. This situation strengthens the hypothesis that tumor suppressor gene inactivation on 8p has more impact on liver carcinogenesis than 8q ampli®cation. According to our data, the minimal overlapping deleted region of chromosome 13 is restricted to band q14. As recently reported by Kusano et al. (1999) , the loss of this chromosomal segment is associated with HCC progression. However in liver, no canonical tumor suppressor gene has yet been identi®ed in 13q14 and mutations of the RB gene have only been described in some rare cases (Zhang et al., 1994) . Frequent loss of heterozygosity for loci on the acrocentric chromosome 14 has been reported in several solid tumor types (Lee et al., 1997 and references therein). In our study, partial loss of chromosome 14 in ®ve out of the seven informative cases designate the 14q23 ± q32 band as the minimal overlapping region of loss. On this chromosome, beside the 14q11 ± q12 bands preferentially lost in lung carcinoma, the 14q23 ± 24.1 and 14q32 segments are suspected to harbor at least two distinct tumor suppressor genes in¯uent in renal cell carcinoma (Schwerdtle et al., 1997) . The respective roles of these loci in pathogenesis still have to be clari®ed. In this context, it has been established that loss of 14q is associated with poor survival in head and neck carcinoma (Lee et al., 1997) .
The only high level copy ampli®cation designed as an amplicon in the present study is mapping to 1q21 ± q23. Together with another tumor showing an interstitial ampli®cation on 1p22 ± q22, the minimal region of ampli®cation could be ascertained to the 1q21 ± q22 band. In the last decade, molecular genetic studies have mainly focused on losses aecting the distal part of chromosome 1p, since this latter region is suspected to contain a tumor suppressor gene in neuroblastoma and many other solid neoplasia (Ragnarsson et al., 1999) . However, in light of recent evidence (Arribas et al., 1999) and the present study, it appears that gains of chromosome 1q are far more prevalent than, and frequently disconnected from 1p loss in HCC. Consequently, we assume the presence at 1q of at least one major proto-oncogene implicated in liver carcinogenesis.
Correlation of specific allelic losses with HBV infection
In an eort to clarify the in¯uence of etiological factors in HCC genetics, we compared the results obtained in the present series of non-B, non-C HCCs with the data of a previous analysis performed on 50 advanced tumors from HBV positive patients (Marchio et al., 1997) . The average number of abnormalities per sample was signi®cantly higher in the HBV(+) tumors when compared with the virus-negative tumors with 7.8 alterations versus 5 respectively (P50.004). The rate of recurrent abnormalities found in the two series are compared in Figure 2 . Chromosome arms 1p, 1q, 6p, 6q, 8p, 8q, 13q, 14q and 17q were aected to a similar extent in the two groups (P40.1). In contrast, a signi®cantly lower rate of losses was observed on chromosomes 4q, 16q and 17p in non-B, non-C HCC samples (with 45, 38 and 29% decrease respectively, P50.001, P50.01 and P50.05, Figure 2 ). These segments losses were among the most prominent alterations detected in tumors of our initial study as well as in the three 1999 reports of virus-infected Asian patients (Kusano et al., 1999; Sakakura et al., 1999; Wong et al., 1999) . Such dierences do not appear to be related with tumor grade. Indeed, they still prevail when we compare tumors of similar grades (grades II and III) from HBsAg(+) and nonB, nonC patients (P50.05). In addition, no signi®cant dierence can be detected according to histological grade among nonB, nonC tumors for chromosomes 4q, 16q and 17p. These results strongly suggest the existence of tumor suppressor genes preferentially associated with viral infection within these three chromosome regions. The Figure 2 Comparison of the frequency of abnormalities in HBV positive patients (Marchio et al., 1997) and HBV/HCV negative patients (present study). Gains are on the upper side of the histogram, losses on the lower side. Informative P values (50.05) were calculated by w 2 test
Oncogene Chromosomal abnormalities in non-B, non-C HCCs A Marchio et al p53 region in 17p might be one of them as it has been reported to be frequently deleted and/or mutated in liver tumors (Puisieux et al., 1997) . Despite the limited number of non-B, non-C HCC cases with 4q loss, three interstitial underrepresented regions de®ned two minimal regions of loss in 4q21 and 4q35. These regions have been described to be similarly deleted in oesophageal and colorectal cancers (Arribas et al., 1999; Rumpel et al., 1999) . Altogether, our data suggest that beside common chromosomal alterations susceptible to aect a large number of solid tumors irrespective of their histological origin and dierentiation status (Mertens et al., 1997) , some`etiology' related genes linked to viral infection may be more particularly involved in liver carcinogenesis. A similar association of molecular changes and etiological factors has been recently described in bladder tumors from Schistosoma hematobium-infected patients (El-Rifai et al., 2000) . The analysis of HCC samples from HCV positive patients will be necessary to elaborate a complete pattern of abnormalities occurring in the course of human hepatocarcinogenesis.
Fibrolamellar carcinoma
To determine possible common as well as speci®c genetic pathways implicated in the development of primary liver cancer, we decided to study, by CGH, chromosomal abnormalities in 10 ®brolamellar carcinomas (FLC), a rare variant subtype of HCC which remains poorly documented.
Among the 10 FLC analysed (Table 1) , three did not reveal any abnormalities. In the remaining seven cases, the number of abnormalities per tumor ranged from 1 to 7 (versus 1 to 12 in`classical' HCCs). The chromosomal abnormalities are listed in Table 2 and schematized by dashed lines in Figure 2 . Gains at chromosome arm 1q represent the most recurrent alteration (6/7 cases versus 19/34 cases in non®brolamellar HCCs). Additional alterations were observed on chromosome arm 8p (n=3), 13q and 14q (two cases each) for losses, and at 8q (n=4) and 6p (n=2) for gains. These regions correspond to those already reported in`classical' HCCs. It is noteworthy that we observed losses of the whole chromosome 18 (n=3) suggesting a frequent monosomy of this chromosome in FLC. Losses of chromosome 18 are rarely reported in HCC but are common in endometrial, colorectal, lung, oesophageal and pancreatic cancers (Jernvall et al., 1999 and references therein) . Two frequently deleted regions corresponding to bands 18q12 and 18q21.1 have been characterized. The latter region harbors the DPC4/SMAD4 tumor suppressor gene, which encodes an essential mediator of the TGFb signaling pathway (Du et al., 1998) . In HCC, 18q is lost in 10 ± 20% of the cases, with a higher frequency in advanced tumors (Kato et al., 1998) . In colorectal and head and neck carcinomas, loss of 18q represents a poor prognostic marker (Jernvall et al., 1999; Pearlstein et al., 1998) . In addition, the 18p11 region has been reported to contain at least two potential tumor suppressor genes implicated in lung, brain and possibly in breast cancer (Tran et al., 1998) .
In the present study, we have shown that, while loss of chromosome 18 seems to be more speci®cally associated with ®brolamellar carcinomas, gains of chromosome arm 1q represents a major abnormality which is common to`classical' HCCs and their FLC subtypes. This chromosome may harbor an important oncogene implicated in the general pathogenesis of liver neoplasia.
Materials and methods
Patients
Among the 270 surgically resected PLCs in Beaujon Hospital between 1989 and 1998, we have retrieved 44 HCC cases (16%) showing neither identi®able risk factors for cirrhosis or extensive ®brosis, nor histological signs of persistent or active chronic hepatitis in non-tumorous liver (Table 1) . HBV surface antigen (HBsAg) and anti-HCV antibodies, available respectively in 42 and 40 patients, were negative in all cases. In order to rule out a possibly cryptic HBV infection, each tumor sample was tested by nested-PCR as previously described (Pineau et al., 1999) . According to the classi®cation of ®brosis by Ishak et al. (1995) , none of the non-tumorous liver tissues exceeded grade I (®brous expension of some were male and 19 female. As usually observed for HCCs developing on a non-cirrhotic liver, the average size of the tumors was large with a mean size of 10+5 cm. Among the 34 non-®brolamellar HCCs, nine tumors were less than 5 cm in diameter, 12 were between 5 and 10 cm and 13 greater than 10 cm. The mean age was signi®cantly lower in FLC (27.6 years) than in the non ®brolamellar group (55.5 years) (P50.001).
Tumor DNA Genomic DNA from frozen tissues was extracted and puri®ed according to Sambrook et al. (1989) .
Comparative genomic hybridization
Metaphase cells for CGH experiments were prepared from phytohemagglutinin (PHA)-stimulated lymphocytes of healthy males. Lymphocyte cultures were synchronized by the thymidine method (Viegas-PeÂ quignot et al., 1978) . CGH was performed according to the procedure described by Kallioniemi et al. (1994) and modi®ed as described by El-Rifai et al. (1997) . In summary, 1 mg of normal male DNA (Sigma) was labeled with Texas red-5-dUTP and -5-dCTP, and 1 mg of tumor DNA with uorescein-12-dUTP and -12-dCTP (Dupont, Wilmington, DE). After hybridization, the slides were washed 2 min in 0.46SSC at 748C and 1 min in 26SSC/0.1% NP40 at room temperature. DNA was counterstained with 0.2 mM DAPI (4,5-diamino-2-phenylindole) in antifade solution. The DNA of each tumor sample was hybridized at least twice. A positive control from a well-characterized neuroblastoma cell-line (IMR 32) was included in each experiment to monitor hybridization quality (Tumilowicz et al., 1970) . Data acquisition and processing
For each hybridization, 6 ± 10 metaphase cells were analysed using a Zeiss axioskop¯uorescence microscope (Zeiss, Germany) and a Quips ®sh digital analysis system (Vysis Inc., USA) which comprises a computer-driven cooled CCD color camera and automated analysis software. Relative changes in the copy number of DNA sequences were both visually evaluated by well-trained observers (A Marchio, M Meddeb, A Bernheim) and analysed using an adapted digital image analysis system (Quips-XL software; Vysis Inc.). Chromosome regions were interpreted as: (1) over-represented if the corresponding color ratio was higher than 1.25; (2) an ampli®cation (high-level-copy number) if higher than 1.8 and (3) under-represented if the ratio was lower than 0.75. The cut-o values were de®ned by analysis of control DNA.
Statistical analysis
The data were analysed using the two-tailed unpaired MannWhitney U-test or the nonparametric chi-square (w 2 ) test as appropriate. The tests were considered signi®cant when the P value was lower than 0.05.
